Rating History for Satsuma Pharmaceuticals (STSA) by H.C. Wainwright
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/18/2023 | Oren Livnat | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.08 (1.10) |
1.85% | Details |
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/18/2023 | Oren Livnat | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.08 (1.10) |
1.85% | Details |
![]() |
|||||||
![]() |
|||||||